These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17239262)

  • 1. Pemetrexed in patients with locally advanced or metastatic breast cancer who had received previous anthracycline and taxane treatment: phase II study.
    Llombart-Cussac A; Theodoulou M; Rowland K; Clark RS; Nakamura T; Carrasco E; Cruciani G
    Clin Breast Cancer; 2006 Dec; 7(5):380-5. PubMed ID: 17239262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phase II study of pemetrexed in patients pretreated with an anthracycline, a taxane, and capecitabine for advanced breast cancer.
    O'Shaughnessy JA; Clark RS; Blum JL; Mennel RG; Snyder D; Ye Z; Liepa AM; Melemed AS; Yardley DA
    Clin Breast Cancer; 2005 Jun; 6(2):143-9. PubMed ID: 16001992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of pemetrexed (ALIMTA, multitargeted antifolate, LY231514) in metastatic breast cancer patients previously treated with an anthracycline and a taxane: an interim analysis.
    Spielmann M; Martin M; Namer M; duBois A; Unger C; Dodwell DJ
    Clin Breast Cancer; 2001 Apr; 2(1):47-51. PubMed ID: 11899382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pemetrexed in relapsed small-cell lung cancer and the impact of shortened vitamin supplementation lead-in time: results of a phase II trial.
    Socinski MA; Raju RN; Neubauer M; Smith DA; Richards DA; Savin M; Ruxer RL; Reynolds CH; Zhan F; Bromund JL; Chen R; Obasaju C
    J Thorac Oncol; 2008 Nov; 3(11):1308-16. PubMed ID: 18978567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase II study of pemetrexed in breast cancer patients pretreated with anthracyclines.
    Martin M; Spielmann M; Namer M; duBois A; Unger C; Dodwell D; Vodvarka P; Lind M; Calvert H; Casado A; Zelek L; Lluch A; Carrasco E; Kayitalire L; Zielinski C
    Ann Oncol; 2003 Aug; 14(8):1246-52. PubMed ID: 12881387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Results of a phase II study of pemetrexed as first-line chemotherapy in patients with advanced or metastatic breast cancer.
    Robert NJ; Conkling PR; O'Rourke MA; Kuefler PR; McIntyre KJ; Zhan F; Asmar L; Wang Y; Shonukan OO; O'Shaughnessy JA
    Breast Cancer Res Treat; 2011 Feb; 126(1):101-8. PubMed ID: 21188632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phase II study of pemetrexed with and without folic acid and vitamin B12 as front-line therapy in malignant pleural mesothelioma.
    Scagliotti GV; Shin DM; Kindler HL; Vasconcelles MJ; Keppler U; Manegold C; Burris H; Gatzemeier U; Blatter J; Symanowski JT; Rusthoven JJ
    J Clin Oncol; 2003 Apr; 21(8):1556-61. PubMed ID: 12697881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phase II trial of pemetrexed and gemcitabine in patients with metastatic breast cancer who have received prior taxane therapy.
    Pippen J; Elias AD; Neubauer M; Stokoe C; Vaughn LG; Wang Y; Orlando M; Shonukan O; Muscato J; O'Shaughnessy JA; Gralow J
    Clin Breast Cancer; 2010 Apr; 10(2):148-53. PubMed ID: 20299319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II trial of Loubo® (Lobaplatin) and pemetrexed for patients with metastatic breast cancer not responding to anthracycline or taxanes.
    Deng QQ; Huang XE; Ye LH; Lu YY; Liang Y; Xiang J
    Asian Pac J Cancer Prev; 2013; 14(1):413-7. PubMed ID: 23534764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase I study of pemetrexed (ALIMTA) and cyclophosphamide in patients with locally advanced or metastatic breast cancer.
    Dittrich C; Petruzelka L; Vodvarka P; Gneist M; Janku F; Kysela T; Melemed A; Latz J; Simms L; Krejcy K
    Clin Cancer Res; 2006 Dec; 12(23):7071-8. PubMed ID: 17145830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of oxaliplatin plus pemetrexed in chemotherapy pretreated metastatic castration-resistant prostate cancer.
    Dorff TB; Tsao-Wei DD; Groshen S; Boswell W; Goldkorn A; Xiong S; Quinn DI; Pinski JK
    Clin Genitourin Cancer; 2013 Dec; 11(4):416-22. PubMed ID: 24099865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of pemetrexed in patients with metastatic renal cancer.
    Thödtmann R; Sauter T; Weinknecht S; Weissbach L; Blatter J; Ohnmacht U; Hanauske A
    Invest New Drugs; 2003 Aug; 21(3):353-8. PubMed ID: 14578684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Experience With Pemetrexed in Breast Cancer.
    Martin M
    Semin Oncol; 2006 Feb; 33(Suppl 2):S15-8. PubMed ID: 16472713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival without common toxicity criteria grade 3/4 toxicity for pemetrexed compared with docetaxel in previously treated patients with advanced non-small cell lung cancer (NSCLC): a risk-benefit analysis.
    Pujol JL; Paul S; Chouaki N; Peterson P; Moore P; Berry DA; Salzberg M
    J Thorac Oncol; 2007 May; 2(5):397-401. PubMed ID: 17473654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma.
    Galsky MD; Mironov S; Iasonos A; Scattergood J; Boyle MG; Bajorin DF
    Invest New Drugs; 2007 Jun; 25(3):265-70. PubMed ID: 17146733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multicenter, single-arm phase II study of pemetrexed plus doxorubicin administered every 21 days in patients with advanced breast cancer.
    Martin M; Blasinska-Morawiec M; Salas JF; Falcon S; Rolski J; Ferrari BL; Gulyas S; Liu Y; Benhadji KA
    Clin Breast Cancer; 2009 Aug; 9(3):155-60. PubMed ID: 19661038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, double-blind, phase II study of two doses of pemetrexed as first-line chemotherapy for advanced breast cancer.
    Llombart-Cussac A; Martin M; Harbeck N; Anghel RM; Eniu AE; Verrill MW; Neven P; De Grève J; Melemed AS; Clark R; Simms L; Kaiser CJ; Ma D
    Clin Cancer Res; 2007 Jun; 13(12):3652-9. PubMed ID: 17575230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II studies of pemetrexed in metastatic breast and gynecologic cancers.
    Smith I
    Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):63-5. PubMed ID: 15655940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pemetrexed disodium in recurrent locally advanced or metastatic squamous cell carcinoma of the head and neck.
    Pivot X; Raymond E; Laguerre B; Degardin M; Cals L; Armand JP; Lefebvre JL; Gedouin D; Ripoche V; Kayitalire L; Niyikiza C; Johnson R; Latz J; Schneider M
    Br J Cancer; 2001 Sep; 85(5):649-55. PubMed ID: 11531245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The optimal duration of vitamin supplementation prior to the first dose of pemetrexed in patients with non-small-cell lung cancer.
    Kim YS; Sun JM; Ahn JS; Ahn MJ; Park K
    Lung Cancer; 2013 Aug; 81(2):231-5. PubMed ID: 23683535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.